obesity drug news today glp-1 oct 27 2025 KFF's survey of Medicaid officials found 16 state Medicaid programs covered GLP-1s for treatment as of October 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC US Views of Weight-Loss Drugs

This decline is the basis for much of the research interest in GHK-Cu spray, since restoring exogenous copper-peptide complex is thought to reactivate signaling pathways that quiet down over time

10.1016/j.cell.2019.03.032 12 AlliA

Other GLP-1 receptor agonists like liraglutide, semaglutide, and dulaglutide are based on modified human GLP-1 sequences, though their development was inspired by the lizard venom discovery

Insulin resistance is one of the leading causes of aging, and improving insulin sensitivity may help slow down the aging process

I would recommend coming to the Saugus location

[button url= Questions